chr21-46228743-C-G

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate

The NM_002340.6(LSS):​c.3G>C​(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).

Frequency

Genomes: not found (cov: 33)

Consequence

LSS
NM_002340.6 start_lost

Scores

1
3
12

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 1.23
Variant links:
Genes affected
LSS (HGNC:6708): (lanosterol synthase) The protein encoded by this gene catalyzes the conversion of (S)-2,3 oxidosqualene to lanosterol. The encoded protein is a member of the terpene cyclase/mutase family and catalyzes the first step in the biosynthesis of cholesterol, steroid hormones, and vitamin D. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 21-46228743-C-G is Pathogenic according to our data. Variant chr21-46228743-C-G is described in ClinVar as [Pathogenic]. Clinvar id is 2861309.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LSSNM_002340.6 linkuse as main transcriptc.3G>C p.Met1? start_lost 1/22 ENST00000397728.8 NP_002331.3
LSSNM_001001438.3 linkuse as main transcriptc.3G>C p.Met1? start_lost 1/23 NP_001001438.1
LSSNM_001145436.2 linkuse as main transcriptc.3G>C p.Met1? start_lost 1/22 NP_001138908.1
LSSNM_001145437.2 linkuse as main transcriptc.-370G>C 5_prime_UTR_variant 1/21 NP_001138909.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LSSENST00000397728.8 linkuse as main transcriptc.3G>C p.Met1? start_lost 1/221 NM_002340.6 ENSP00000380837.2 P48449-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpNov 24, 2023This sequence change affects the initiator methionine of the LSS mRNA. The next in-frame methionine is located at codon 81. This variant is not present in population databases (gnomAD no frequency). Disruption of the initiator codon has been observed in individual(s) with clinical features of LSS-related disorders (PMID: 35413293; Invitae). It has also been observed to segregate with disease in related individuals. Studies have shown that disruption of the initiator codon alters LSS gene expression (PMID: 35413293). This variant disrupts a region of the LSS protein in which other variant(s) (p.Tyr14Cys) have been observed in individuals with LSS-related conditions (PMID: 30723320). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
19
DANN
Benign
0.97
DEOGEN2
Benign
0.091
T;T;.
Eigen
Benign
-0.75
Eigen_PC
Benign
-0.82
FATHMM_MKL
Benign
0.020
N
LIST_S2
Uncertain
0.90
.;D;D
M_CAP
Uncertain
0.26
D
MetaRNN
Pathogenic
0.97
D;D;D
MetaSVM
Benign
-1.0
T
PROVEAN
Benign
-0.87
N;N;N
REVEL
Benign
0.15
Sift
Uncertain
0.018
D;D;D
Sift4G
Benign
0.19
T;T;T
Polyphen
0.043
B;B;.
Vest4
0.75
MutPred
1.0
Loss of MoRF binding (P = 0.0735);Loss of MoRF binding (P = 0.0735);Loss of MoRF binding (P = 0.0735);
MVP
0.25
ClinPred
0.96
D
GERP RS
1.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.77
gMVP
0.65

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr21-47648657; API